Pharma major Dr Reddy’s Laboratories Ltd has launched five new generic drugs in the US market in January 2009. The products launched were Levetiracetam tablets (the generic version of UCB Keppra) with annual sales of $1.1 billion in 2008, Omeprazole capsules (the generic version of AstraZeneca’s Prilosec DR) with annual sales of $168 million, and Lamotragine CD chewable tablets (generic version of GlaxoSmithKline’s Lamictal) which had annual sale of $87 million.

Besdies, Divalproex capsules and delayed release pellets (generic version of Abbott’s Depakote) with annual sales of $126 million and Lamotrigine tablets (generic version of GlaxoSmithKline’s Lamictal) with annual sales of $2.3 billion were also launched. These five products add additional breadth and depth to the company’s product portfolio.

crackcrack

Dr. Reddys Lab Share Price

6171.85 124.25 (2.05%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.